Overview
2cureX provides genomic analysis and personalized treatment recommendations for cancer patients by analyzing tumor DNA and RNA to identify targeted therapy options. The company enables oncologists to match individual patients with precision medicines based on their specific genetic mutations and disease characteristics.
More in Genetic Testing
Latest industry news
Genomic Sovereignty in MENA: How the Region Is Building Its Own Precision Medicine Foundation
2026-10-12 · Industry
Vietnam's Gene Solutions Eyes Hong Kong IPO to Fund Southeast Asian Genomics Expansion
2026-10-11 · Industry
NeoGenomics FDA-Approved PTEN Test Raises the Question: Is the Stock Undervalued?
2026-10-10 · Product
Current Genetic Testing in Cancer May Miss Most Inherited Gene Variants, Study Warns
2026-10-09 · Research
Company details
Is this your company?
Claim this listing to add your logo, full description, and products. Premium listings get featured placement.
Claim & upgrade listingAdvertise
Reach genomics professionals
Newsletter sponsorships, featured listings, and sponsored articles.
View packages →